The injunction is a loss for Gov. Sarah Sanders and a win for CVS, which previously said the state law likely would have ...

Pharmacy giant CVS is facing several lawsuits over allegedly sending text messages to customers to avoid a Louisiana law against PBM business ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

CVS Health Corporation CVS is scheduled to report second-quarter 2025 results on July 31, before the opening bell. In the ...

Unique to CVS Caremark Corporation (NYSE:CVS) is Caremark’s ability to offer 90-day supplies of drugs at mail-order prices. CVS can mail them or provide them for pick up at its stores.

CVS Caremark Corporation (NYSE:CVS) is one of my favorite “safety” stocks, that is, a company that is well positioned to do well in any type of economic environment. - Part 2 ...

CVS Caremark, Express Scripts and OptumRx processed almost 80% of the 6.6 billion prescriptions filled nationwide last year, according to a Federal Trade Commission preliminary report released ...

CVS Caremark Corp. et al., ordering CVS Caremark to pay the U.S. government $95 million. Relator Sarah Behnke brought a qui tam action in February 2014 under the False Claims Act against CVS ...

CVS Caremark Indemnity whose parent company is CVS Health Corporation (CVS Health), assumes Medicare Part D business from an affiliated insurance company, SilverScript Insurance Company ...

Retail pharmacy giant CVS announced on Feb. 5 that it would stop selling cigarettes and other tobacco products in its 7,600 stores by October 1 of this year. Although CVS Caremark reports the ...

Target Corporation announced this week that it would sell its network of pharmacies to none other than CVS Caremark . The deal is valued at $1.9 billion and marks an unlikely partnership between ...

CVS Caremark Corporation announced that its 4th quarter net income fell to $1.03 billion, or 75 cents per share, down from $1.05 billion, or 74 cents per share, a year earlier.